SCHEMBL2812447

SCHEMBL2812447

COc1cccc(OC)c1OC=C(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA7 P43166 1/20 0.47
CA14 Q9ULX7 1/20 0.47
ALDH1A1 P00352 2/20 0.45
NFE2L2 Q16236 2/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
GAA P10253 1/20 0.42
TLR2 O60603 1/20 0.42
ERN1 O75460 1/20 0.42
TLR1 Q15399 1/20 0.42
TLR6 Q9Y2C9 1/20 0.42
KDM4E B2RXH2 4/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41
HSD17B10 Q99714 1/20 0.41
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812445 1.00 CA12 (0.47) CA12CA1CA2CA9CA7
SCHEMBL2809046 0.84 SMN1; SMN2 (0.47) CA12CA1CA2CA9CA7
SCHEMBL2809048 0.84 SMN1; SMN2 (0.47) CA12CA1CA2CA9CA7
SCHEMBL2811883 0.81 HIF1A (0.47) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL2811877 0.81 HIF1A (0.47) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL12851395 0.80 LMNA (0.50) ALDH1A1NFE2L2MEN1KMT2AGAA
SCHEMBL12853897 0.80 SMN1; SMN2 (0.45) CA12CA1CA2CA9CA7
SCHEMBL7076716 0.77 KMT2A (0.44) ALDH1A1KMT2AKDM4ELMNAHSD17B10
SCHEMBL20970610 0.77 NFE2L2 (0.58) NFE2L2KMT2ATLR2ERN1TLR1
SCHEMBL23457707 0.76 NFE2L2 (0.42) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103827158-A (meth)acryloyl-terminated polyisobutylene polymer, method for producing same, and active energy ray-curable composition KANEKA CORP 2014-05-28 CN disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 CA12 3493/4885CA1 1622/4885CA2 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.